ClinicalTrials.Veeva

Menu

Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer

R

Radboud University Medical Center

Status

Completed

Conditions

Colonic Neoplasms
Neoplasm Recurrence, Local

Study type

Observational

Funder types

Other

Identifiers

NCT05475288
K20.306

Details and patient eligibility

About

Data on disease recurrence was collected for all primary colon cancer patients diagnosed in the Netherlands over the first six months of 2015. Three-year cumulative incidence, risk factors, treatment and three-year OS of locoregionally recurrent colon cancer were determined.

Enrollment

3,554 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed stage I-III primary colon carcinoma;
  • Diagnosed between January 1st and June 30th of 2015;
  • Surgical resection of primary colon carcinoma.

Exclusion criteria

  • Appendiceal localization;
  • Neuroendocrine tumor morphology;

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems